Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 8 cyclopia sequence 7 Prostatic Neoplasms 7 Polycystic Ovary Syndrome 5 Fatigue 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pain 3 Obesity 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Leiomyoma 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neoplasms, Plasma Cell 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Insulin Resistance 2 Infertility 2 Hyperandrogenism 2 Hematologic Diseases 2 Depression 2 Burkitt Lymphoma 2 Weight Loss 1

Interventions

Octreotide 6 Irinotecan 6 Loperamide 5 Probiotics 3 Leucovorin 3 Fluorouracil 3 Fecal Microbiota Transplantation 3 Calcium Aluminosilicate 3 maltodextrin 2 telotristat ethyl 1 shosaiko-to 1 lanreotide 1 isatuximab 1 ceterizine hydrochloride 1 capivasertib 1 cabazitaxel 1 bile acid binding proteins 1 XRP6258 1 Theophylline 1 Temozolomide 1 Surveys and Questionnaires 1 Sulfasalazine 1 Sugars 1 Standard of Care 1 Raloxifene Hydrochloride 1 Radiation 1 Prednisone 1 PHY 906 1 Oxaliplatin 1 Long-Term Synaptic Depression 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diarrhea × Sugars × Clear all

NCT02018653 2018-07-26

CASAD for Severe Diarrhea in the Emergency Department

M.D. Anderson Cancer Center

Phase NA Terminated

2 enrolled 5 charts

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡